The Affordability Crisis in Indian Healthcare
Healthcare costs remain a significant burden for millions of Indian families. Out-of-pocket spending on medicines accounts for the largest share of healthcare expenditure in India. In this context, generic medicines represent one of the most powerful tools for making healthcare accessible to all.
Yet, myths and misconceptions about generic medicines persist. Many patients believe that cheaper means lesser quality. This guide sets the record straight.
What Are Generic Medicines?
A generic medicine is a pharmaceutical product that:
- Contains the same active ingredient as the original branded drug
- Is available in the same dosage form and strength
- Is administered by the same route
- Has equivalent bioavailability — meaning it reaches the bloodstream at the same rate and to the same extent
The only differences are the name, appearance, packaging, and price.
The Science of Bioequivalence
Before a generic medicine can be approved, manufacturers must prove bioequivalence — that the generic drug behaves in the same way in the body as the original.
This is demonstrated through pharmacokinetic studies measuring:
- Cmax (maximum drug concentration in blood)
- Tmax (time to reach maximum concentration)
- AUC (area under the concentration-time curve — total drug exposure)
Regulatory agencies require these parameters to fall within 80–125% of the original drug's values. In practice, most generics are within 3–5% of the original.
Why Are Generics So Much Cheaper?
The price difference is not about quality — it is about economics:
| Cost Factor | Branded Drug | Generic Drug |
|---|---|---|
| Very high | ||
| Very high | ||
| Yes (20 years) | ||
| High | ||
| No |
When a patent expires, multiple manufacturers can produce the same molecule, creating price competition that dramatically reduces costs.
India: The Pharmacy of the World
India is the world's largest exporter of generic medicines by volume, supplying over 20% of global generic drug exports. Indian pharmaceutical companies produce medicines for the US, UK, EU, Australia, and more — all under stringent quality oversight.
This reputation was hard-earned through investment in quality, technology, and regulatory compliance.
Jan Aushadhi Scheme
The Government of India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) operates Jan Aushadhi Kendras across India, selling generic medicines at prices 50–90% lower than branded equivalents. This initiative has brought vital medicines within reach of millions of citizens.
Choosing Quality Generic Medicines
Not all generic manufacturers operate to the same standards. When choosing generic medicines:
- 1Choose licensed manufacturers with WHO-GMP or Schedule M compliance
- 2Look for CDSCO approval on the packaging
- 3Check the manufacturing date and expiry
- 4Buy from registered pharmacies
- 5Consult your doctor if switching from a branded to generic medicine for a chronic condition
At Mithilanchal Pharma, we are committed to producing generic medicines that meet the highest quality standards, making reliable healthcare affordable for every Indian family. Our manufacturing follows strict GMP protocols. Learn about our quality commitment →.
The Future of Generic Medicines in India
With the government's push for generic prescribing and the expansion of Jan Aushadhi Kendras, India's generic medicine market is expected to grow significantly. This is good news for patients — more competition means better prices and wider availability.
The key is ensuring that "affordable" never means "substandard." Quality generics, manufactured by responsible companies, represent healthcare equity in action.